Therapeutic targeting of PP2A
Keywords: Protein phosphatase 2A; PP2A; SET; CIP2A; PME-1; LCMT-1; FTY720; OP449; Bortezomib; Erlotinib; Celastrol; ABL-127; SMAPs; Phenothiazines; LB-100; Protein phosphatases; Drug development; Cancer; Cell signaling; Tumor suppressors;